MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A

被引:195
作者
Loercher, AE [1 ]
Tank, EMH [1 ]
Delston, RB [1 ]
Harbour, JW [1 ]
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
关键词
D O I
10.1083/jcb.200410115
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cell cycle exit is required for proper differentiation in most cells and is critical for normal development, tissue homeostasis, and tumor suppression. However, the mechanisms that link cell cycle exit with differentiation remain poorly understood. Here, we show that the master melanocyte differentiation factor, microphthalmia transcription factor (MITF), regulates cell cycle exit by activating the cell cycle inhibitor INK4A, a tumor suppressor that frequently is mutated in melanomas. MITF binds the INK4A promoter, activates p16(Ink4a) mRNA and protein expression, and induces retinoblastoma protein hypopkosphorylation, thereby triggering cell cycle arrest. This activation of INK4A was required for efficient melanocyte differentiation. Interestingly, MITF was also required for maintaining INK4A expression in mature melanocytes, creating a selective pressure to escape growth inhibition by inactivating INK4A. These findings demonstrate that INK4A can be regulated by a differentiation factor, establish a mechanistic link between melanocyte differentiation and cell cycle exit, and potentially explain the tissue-specific tendency for INK4A mutations to occur in melanoma.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 23 条
[1]  
Bear J, 2003, DEVELOPMENT, V130, P6545
[2]   Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after γ-irradiation [J].
Brugarolas, J ;
Moberg, K ;
Boyd, SD ;
Taya, Y ;
Jacks, T ;
Lees, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1002-1007
[3]   Malignant melanoma: modern black plague and genetic black box [J].
Chin, L ;
Merlino, G ;
DePinho, RA .
GENES & DEVELOPMENT, 1998, 12 (22) :3467-3481
[4]   Transducible peptide therapy for uveal melanoma and retinoblastoma [J].
Harbour, JW ;
Worley, L ;
Ma, DD ;
Cohen, M .
ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) :1341-1346
[5]   A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation [J].
Ikeda, M ;
Jakoi, L ;
Nevins, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3215-3220
[6]  
Kastner A, 1998, CELL GROWTH DIFFER, V9, P857
[7]   The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2 [J].
Kitagawa, M ;
Higashi, H ;
Jung, HK ;
SuzukiTakahashi, I ;
Ikeda, M ;
Tamai, K ;
Kato, J ;
Segawa, K ;
Yoshida, E ;
Nishimura, S ;
Taya, Y .
EMBO JOURNAL, 1996, 15 (24) :7060-7069
[8]   The retinoblastoma gene family in differentiation and development [J].
Lipinski, MM ;
Jacks, T .
ONCOGENE, 1999, 18 (55) :7873-7882
[9]   Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb [J].
Ma, DD ;
Zhou, P ;
Harbour, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (21) :19358-19366
[10]   Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability [J].
McGill, GG ;
Horstmann, M ;
Widlund, HR ;
Du, JY ;
Motyckova, G ;
Nishimura, EK ;
Lin, YL ;
Ramaswamy, S ;
Avery, W ;
Ding, HF ;
Jordan, SA ;
Jackson, IJ ;
Korsmeyer, SJ ;
Golub, TR ;
Fisher, DE .
CELL, 2002, 109 (06) :707-718